HOME | SynapCell

Revealing Your Drug Efficacy


SynapCell is a Preclinical Biotechnology company inspired by patients.


We reveal the therapeutic potential
of pharmaceutical compounds that target Brain diseases.
Our unique Predictive decision-making assays help our clients worldwide
draw a clearer path to their clinical success.


#STOP GUESSING



BROWSE THE LINKS BELOW TO DISCOVER OUR CAPABILITIES

FOR YOUR PRECLINICAL DRUG DISCOVERY STUDIES



v

Epileptic
Disorders
AED efficacy evaluation
using predictive EEG biomarkers and models of epilepsy
Cognitive
Disorders
Accurate identification
of defects in information processing
Movement
Disorders
Non behavior-related measures
of motor dysfunction within the brain

News & Events

Neuroscience 2017

Washington, DC | Nov 11-15 2017

ECNP 2017

Paris, France | Sep 2-5 2017

A Word about AED Trials

Miami, USA | June 2017

AED TRIALS XIV

Miami, USA | May 17-19 2017

SynapCell at AD/PD 2017

Vienna, Austria | March 29 - April 2, 2017

SynapCell selected as key partner of the ETSP

Grenoble and Salt Lake City | 03/11/2016

Neuroscience 2016

San Diego, USA | 12 - 16 NOV 2016

EILAT XIII Conference: Attending?

Madrid, Spain | 26 - 29 June 2016

MDS 2016 - Let's meet in Berlin!

Berlin, Germany | 19 - 23 June 2016

A word about Neuroscience 2015

Chicago | 17 - 21 October 2015

Neuroscience 2015 - Stop guessing

Chicago | 17 - 21 October 2015